Powder Delivery TRIZ Cases

Inhaled roflumilast N-oxide treats COPD via local quality while reducing systemic side effects.

Vibrating mesh nebulizers generate optimal peptide aerosols for lung delivery.

Purified bacterial strains combined with taurine suppress multidrug-resistant organisms while maintaining gut microbiome balance.

Labile covalent linkages in masked polyamine conjugates resolve toxicity and bioavailability trade-offs by enabling controlled release of polynucleotides.

Casein nanoparticles reduce systemic toxicity by targeting cancer cells, avoiding harm to healthy tissue.

Liquid D-HAF replaces invasive membrane surgery, reducing application frequency while sustaining therapeutic benefits.

Engineered protuberances fit into cavities to stabilize recombinant peptide-MHC monomers, resolving low yield and immunogenicity trade-offs.

An inorganic lamellar component intercalates pharmacologically active substances into a polymer matrix, enabling controlled release over extended periods.

Recombinant human alpha-galactosidase-A proteins with altered glycosylation profiles produced using chemically-defined media.

Infold agents target conserved hemagglutinin regions to overcome seasonal vaccine limitations and emerging drug resistance across multiple viral strains.

Polymerized tetraethylorthosilicate shells protect payloads from thermal and hydrolase degradation during oral delivery.

Amorphous intranasal powder overcomes low solubility of crystalline agents, boosting relative bioavailability via freeze-dried formulation.

Thermosensitive nanoparticles release medications at specific temperatures, minimizing thermal damage to healthy cells during tumor treatment.

Segmenting antimicrobial cores from phage-binding surfaces resolves antibiotic resistance by enabling targeted bacterial lysis without off-target effects.

A caspofungin and polyvinylpyrrolidone composition delivers high lung concentrations via inhalation.

Defining specific particle size ranges resolves segregation issues in waxy cetyl myristate manufacturing.

Low temperature drying removes solvents from drug-containing polymeric compositions without degrading therapeutic agents.

Collagen methacrylamide undergoes UV-induced photopolymerization to form tunable hydrogels without cytotoxic chemical cross-linkers.

A dissolvable pouch material eliminates pouring actions to transfer crushed medication directly into liquid beverages.

Stool purification and lyophilization stabilize gut microbiota to treat Clostridium difficile infections without antibiotic resistance.

Spray drying diketopiperazine-insulin particles enhances aerodynamic performance and stability.

Dofetilide targets Kv11.1 channels to reverse pulmonary hypertension vascular remodeling, addressing limited treatment options.

Covalent polymer networks conjugate proteins to eliminate electrostatic fouling and enable traceless release in specific microenvironments.

Sequential laser irradiation heats magnetosomes to destroy tumor cells, replacing bulky induction systems with compact optical sources.

Pyranone compounds modulate OMA1 protease activity, addressing the complexity of treating mitochondrial dysfunction and OPA1 alterations.

Self-assembled bi-concaved disc-shaped nanoparticles resolve biological instability and rapid reticuloendothelial uptake through hydrophobic modification.

Replacing electrolytes with glucose maintains isotonicity while preventing particle enlargement and preserving immunostimulating features.

Standardizing glyceride mass percentages through supercritical extraction resolves quality control challenges in Kanglaite injection.

Beam splitters separate fluorescence and Raman signals to resolve interference from autofluorescence, enabling accurate in-vivo disease diagnosis.

Laquinimod targets TLR7 pathways to improve renal function and reduce proteinuria while avoiding broad immunosuppression side effects.

Quinoline compounds reduce toxic aldehyde levels by scavenging escaped retinaldehyde, treating inflammatory and ocular disorders.

Triglyceride excipients in the lipid matrix extend API residence time in lungs, improving local tolerance and patient compliance.

Poly[bis(trifluoroethoxy)phosphazene] particles provide long-term stability and facilitate effective delivery of active agents.

Plasmonic nanoparticles amplify initiation energy to activate pharmaceutical agents in situ.

Composite implants anchor viable cells within a growth-conductive matrix, resolving the contradiction between tissue integration and component stability.

Multi-source ethanol plant extracts lower lipid levels and control blood pressure while minimizing adverse effects from synthetic drugs.

Intermittent parathyroid hormone administration promotes bone formation to reduce femoral head collapse in idiopathic osteonecrosis.

A lighting module delivers near-infrared light through the foramen magnum while providing hydrogen therapy.

Poloxamer surfactants stabilize parathyroid hormone solutions against aggregation, enabling room temperature storage without refrigeration.

A suction actuated valve uses a displaceable membrane to provide mechanical advantage, resolving weak user inhalation force limitations.

Bronchial artery catheterization distributes radioactive microparticles to treat multiple lung lesions while preserving residual lung capacity.

Electrophoretic ion migration deforms biopolymer capsules under electric fields to release actives without direct electrode contact.

Histidine buffering reduces acidic variant accumulation while maintaining biological activity.

Putty-like absorbable bone wax controls bleeding while stimulating bone growth without inhibiting osteogenesis.

A melatonin tablet dissolves the hormone in a solvent absorbed onto a carrier to maintain solubility.

Particulate magnesium stearate protects active compounds from oxidative degradation and hydrolytic cleavage in dry powder inhalation formulations.

Solubility-enhancing agents enable oxcarbazepine formulations to achieve tailored sigmoidal release profiles for once-daily dosing.

A nanoparticle core coated with a C16-acylated human lactoferrin-derived peptide promotes cellular uptake of active pharmaceutical ingredients.